












Steven Lin
Founder at FinalDose
Cofounder and CTO at FinalDose (YC P26). Oxford PhD in Computational Biology with Wellcome Trust full scholarship. Previously Data Lead at Gutsee Biotech. Developed novel machine learning method to use coevolution biology to identify genetic targets that convey drug resistance in viruses. During SARS-CoV-2 pandemic, led UK biobank analysis of human genetics susceptibility for infections
Follow Steven
Previously at
Gutsee Biotech

University of Oxford
Alumnus of

University of Oxford

Imperial College London